These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 15374956
1. The role of DNA polymerase eta in translesion synthesis past platinum-DNA adducts in human fibroblasts. Bassett E, King NM, Bryant MF, Hector S, Pendyala L, Chaney SG, Cordeiro-Stone M. Cancer Res; 2004 Sep 15; 64(18):6469-75. PubMed ID: 15374956 [Abstract] [Full Text] [Related]
2. Overproduction of DNA polymerase eta does not raise the spontaneous mutation rate in diploid human fibroblasts. King NM, Nikolaishvili-Feinberg N, Bryant MF, Luche DD, Heffernan TP, Simpson DA, Hanaoka F, Kaufmann WK, Cordeiro-Stone M. DNA Repair (Amst); 2005 Jun 08; 4(6):714-24. PubMed ID: 15886068 [Abstract] [Full Text] [Related]
3. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro. Bassett E, Vaisman A, Havener JM, Masutani C, Hanaoka F, Chaney SG. Biochemistry; 2003 Dec 09; 42(48):14197-206. PubMed ID: 14640687 [Abstract] [Full Text] [Related]
4. Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts. Vaisman A, Lim SE, Patrick SM, Copeland WC, Hinkle DC, Turchi JJ, Chaney SG. Biochemistry; 1999 Aug 24; 38(34):11026-39. PubMed ID: 10460158 [Abstract] [Full Text] [Related]
5. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts. Chaney SG, Campbell SL, Bassett E, Wu Y. Crit Rev Oncol Hematol; 2005 Jan 24; 53(1):3-11. PubMed ID: 15607931 [Abstract] [Full Text] [Related]
6. Decreased frequency and highly aberrant spectrum of ultraviolet-induced mutations in the hprt gene of mouse fibroblasts expressing antisense RNA to DNA polymerase zeta. Diaz M, Watson NB, Turkington G, Verkoczy LK, Klinman NR, McGregor WG. Mol Cancer Res; 2003 Sep 24; 1(11):836-47. PubMed ID: 14517346 [Abstract] [Full Text] [Related]
7. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta. Vaisman A, Masutani C, Hanaoka F, Chaney SG. Biochemistry; 2000 Apr 25; 39(16):4575-80. PubMed ID: 10769112 [Abstract] [Full Text] [Related]
8. Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases beta and eta. Bassett E, Vaisman A, Tropea KA, McCall CM, Masutani C, Hanaoka F, Chaney SG. DNA Repair (Amst); 2002 Dec 05; 1(12):1003-16. PubMed ID: 12531010 [Abstract] [Full Text] [Related]
9. Adenovirus mediated transduction of the human DNA polymerase eta cDNA. Lima-Bessa KM, Chiganças V, Stary A, Kannouche P, Sarasin A, Armelini MG, de Fátima Jacysyn J, Amarante-Mendes GP, Cordeiro-Stone M, Cleaver JE, Menck CF. DNA Repair (Amst); 2006 Aug 13; 5(8):925-34. PubMed ID: 16798111 [Abstract] [Full Text] [Related]
10. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells. Chijiwa S, Masutani C, Hanaoka F, Iwai S, Kuraoka I. Carcinogenesis; 2010 Mar 13; 31(3):388-93. PubMed ID: 20015866 [Abstract] [Full Text] [Related]
11. Comparative analysis of the mutagenic activity of oxaliplatin and cisplatin in the Hprt gene of CHO cells. Silva MJ, Costa P, Dias A, Valente M, Louro H, Boavida MG. Environ Mol Mutagen; 2005 Aug 13; 46(2):104-15. PubMed ID: 15887215 [Abstract] [Full Text] [Related]
12. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage. Albertella MR, Green CM, Lehmann AR, O'Connor MJ. Cancer Res; 2005 Nov 01; 65(21):9799-806. PubMed ID: 16267001 [Abstract] [Full Text] [Related]
13. DNA polymerase eta, a key protein in translesion synthesis in human cells. Cruet-Hennequart S, Gallagher K, Sokòl AM, Villalan S, Prendergast AM, Carty MP. Subcell Biochem; 2010 Nov 01; 50():189-209. PubMed ID: 20012583 [Abstract] [Full Text] [Related]
14. Protein interactions with platinum-DNA adducts: from structure to function. Chaney SG, Campbell SL, Temple B, Bassett E, Wu Y, Faldu M. J Inorg Biochem; 2004 Oct 01; 98(10):1551-9. PubMed ID: 15458816 [Abstract] [Full Text] [Related]
15. The role of DNA polymerase eta in UV mutational spectra. Choi JH, Pfeifer GP. DNA Repair (Amst); 2005 Feb 03; 4(2):211-20. PubMed ID: 15590329 [Abstract] [Full Text] [Related]
16. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts. Vaisman A, Varchenko M, Umar A, Kunkel TA, Risinger JI, Barrett JC, Hamilton TC, Chaney SG. Cancer Res; 1998 Aug 15; 58(16):3579-85. PubMed ID: 9721864 [Abstract] [Full Text] [Related]
17. Adduct size limits efficient and error-free bypass across bulky N2-guanine DNA lesions by human DNA polymerase eta. Choi JY, Guengerich FP. J Mol Biol; 2005 Sep 09; 352(1):72-90. PubMed ID: 16061253 [Abstract] [Full Text] [Related]
18. Increased susceptibility to UV-induced skin carcinogenesis in polymerase eta-deficient mice. Lin Q, Clark AB, McCulloch SD, Yuan T, Bronson RT, Kunkel TA, Kucherlapati R. Cancer Res; 2006 Jan 01; 66(1):87-94. PubMed ID: 16397220 [Abstract] [Full Text] [Related]
19. Specificity of platinum-DNA adduct repair. Chaney SG, Vaisman A. J Inorg Biochem; 1999 Oct 01; 77(1-2):71-81. PubMed ID: 10626357 [Abstract] [Full Text] [Related]
20. Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta. Alt A, Lammens K, Chiocchini C, Lammens A, Pieck JC, Kuch D, Hopfner KP, Carell T. Science; 2007 Nov 09; 318(5852):967-70. PubMed ID: 17991862 [Abstract] [Full Text] [Related] Page: [Next] [New Search]